chr2-134981239-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_025052.5(MAP3K19):​c.3502A>G​(p.Lys1168Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

MAP3K19
NM_025052.5 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.684
Variant links:
Genes affected
MAP3K19 (HGNC:26249): (mitogen-activated protein kinase kinase kinase 19) Predicted to enable ATP binding activity; protein serine kinase activity; and protein serine/threonine kinase activity. Predicted to be involved in protein phosphorylation. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19048601).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MAP3K19NM_025052.5 linkuse as main transcriptc.3502A>G p.Lys1168Glu missense_variant 12/13 ENST00000392915.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MAP3K19ENST00000392915.7 linkuse as main transcriptc.3502A>G p.Lys1168Glu missense_variant 12/135 NM_025052.5 P2Q56UN5-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 07, 2023The c.3502A>G (p.K1168E) alteration is located in exon 9 (coding exon 9) of the MAP3K19 gene. This alteration results from a A to G substitution at nucleotide position 3502, causing the lysine (K) at amino acid position 1168 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
15
DANN
Uncertain
0.98
DEOGEN2
Benign
0.023
T;T;.;.;.;.;.
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.62
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.77
.;T;T;T;T;T;T
M_CAP
Benign
0.0077
T
MetaRNN
Benign
0.19
T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L;L;.;.;.;.;.
MutationTaster
Benign
1.0
D;N;N;N;N;N;N
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-2.7
.;D;D;D;D;D;N
REVEL
Benign
0.031
Sift
Benign
0.087
.;T;T;T;D;D;T
Sift4G
Benign
0.094
.;T;T;T;T;T;T
Polyphen
0.034
B;B;.;B;B;B;.
Vest4
0.25, 0.28, 0.28, 0.28, 0.28
MutPred
0.69
Loss of methylation at K1168 (P = 0.0228);Loss of methylation at K1168 (P = 0.0228);.;.;.;.;.;
MVP
0.19
MPC
0.20
ClinPred
0.064
T
GERP RS
0.84
Varity_R
0.21
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr2-135738809; API